COMMUNIQUÉS West-GlobeNewswire

Serina Therapeutics to Present at the 4th LNP Formulation & Process Development Summit
15/04/2025
HUNTSVILLE, AL, April 15, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform ™ drug optimization technology [...]
Native Path Native Hydrate Reviews [Urgent Update]: Don’t Buy Until You Read This
15/04/2025
Native Hydrate by Native Path Reviews Woodhaven, N.Y., April 15, 2025 (GLOBE NEWSWIRE) -- What if the key to better hydration and muscle recovery wasn’t in sugary sports drinks but in a clean, science-backed formula? [...]
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2025
15/04/2025
Company Announcement Net sales of DARZALEX ® in the first quarter of 2025 totaled USD 3,237 million Genmab receives royalties on worldwide net sales from Johnson & Johnson (J&J, legal entity Janssen Biotech, Inc [...]
Verona Pharma to Report First Quarter 2025 Financial Results and Provide Corporate Update
15/04/2025
LONDON and RALEIGH, N.C., April 15, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”) announces that it will report its financial results for the first quarter ended March 31, [...]
Best Diabetes Supplement of 2025: Learn How GlucoRedi Sets a New Benchmark in Wellness Industry
15/04/2025
Nampa, April 15, 2025 (GLOBE NEWSWIRE) -- Best Diabetes Supplement of 2025: Learn How GlucoRedi Sets a New Benchmark in Wellness Industry Glucoredi diabetes supplement Content Promoted By Branding EX Solution pvt ltd ( [...]
Genenta Showcases Strategic Vision at Premier Biotech Forum in Qatar
15/04/2025
MILAN and NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- Pierluigi Paracchi , CEO Genenta Science (Nasdaq: GNTA), a pioneer in immuno-oncology and a leader in cell-based therapeutics, will present at “Montalcini Global [...]
HepaRegeniX completes €21.5 million financing to support clinical advancement of HRX-215 for liver regeneration
15/04/2025
Tuebingen, Germany, April 15, 2025 – HepaRegeniX GmbH (“HepaRegeniX”), a clinical-stage company advancing novel therapies to treat acute and chronic liver diseases, today announced the second closing and completion of a [...]
How to Lower Blood Sugar Naturally: A Comprehensive Review of GlucoRedi, the Best Diabetes Supplement
15/04/2025
Nampa, April 15, 2025 (GLOBE NEWSWIRE) -- How to Lower Blood Sugar Naturally: A Comprehensive Review of GlucoRedi, the Best Diabetes Supplement Glucoredi diabetes control supplement Content promoted through the Branding [...]
Concept Life Sciences expands expertise with key appointments to Scientific Advisory Board and investments to strengthen integrated drug discovery capabilities
15/04/2025
- Appointments come as the business invests a six-figure sum into advanced technology and systems - CHAPEL-EN-LE-FRITH, United Kingdom, April 15, 2025 (GLOBE NEWSWIRE) -- Concept Life Sciences (CLS), a leading [...]
Oculis Hosts R&D Event Today to Showcase Progress on All Three Pipeline Assets
15/04/2025
ZUG, Switzerland, April 15, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis” or the “Company"), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro- [...]
Oculis Hosts R&D Event Today to Showcase Progress on All Three Pipeline Assets
15/04/2025
ZUG, Switzerland, April 15, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis” or the “Company"), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro- [...]
Statutory negotiations at Orion's R&D unit in Turku, Finland have been concluded
15/04/2025
ORION CORPORATION PRESS RELEASE 15 April 2025 at 10.00 EEST Statutory negotiations at Orion's R&D unit in Turku, Finland have been concluded Orion Corporation announced in a press release on 10 March 2025 that the [...]
Cyprumed Enters License and Option Agreement with MSD for the Development of Oral Peptide Therapeutics
15/04/2025
MSD obtains a Non-Exclusive License for Cyprumed’s delivery technology to develop oral peptide therapeutics Cyprumed will be eligible to receive up to $493 million in upfront, development, regulatory and sales [...]
Correction: Private placement of 25,000,000 new shares fully subscribed – gross proceeds of DKK 33.5 million, to BioPorto A/S
15/04/2025
April 15, 2025 Announcement no. 11 Private placement of 25,000,000 new shares fully subscribed – gross proceeds of DKK 33.5 million, to BioPorto A/S Copenhagen, Denmark, April 15, 2025, (GLOBE NEWSWIRE) – BioPorto A/S [...]
Private placement of 25,000,000 new shares fully subscribed – gross proceeds of DKK 33.5 million, to BioPorto A/S
15/04/2025
April 15, 2025 Announcement no. 11 Private placement of 25,000,000 new shares fully subscribed – gross proceeds of DKK 33.5 million, to BioPorto A/S Copenhagen, Denmark, April 15, 2025, (GLOBE NEWSWIRE) – BioPorto A/S [...]
Boehringer Ingelheim and Cue Biopharma partner to develop next-generation treatment for autoimmune and inflammatory diseases
15/04/2025
Partnership bolsters Boehringer’s autoimmune and inflammatory disease pipeline portfolio aiming to tackle areas of high unmet patient need. The agreement focuses on further research and development of a novel, first-in- [...]
CORXEL Receives Study May Proceed Letter from the U.S. FDA for the Phase 2 Trial of CX11 in Patients with Obesity and Overweight Conditions
15/04/2025
The U.S. Phase 2 trial aims to evaluate efficacy and safety of CX11 in doses up to 200 mg and different titration schemes The trial is expected to enroll 250 patients to receive treatment over 36 weeks BERKELEY HEIGHTS [...]
Galapagos Announces Departure of Thad Huston, CFO and COO, as of August 1, 2025
15/04/2025
Mechelen, Belgium; April 15, 2025, 07:30 CET; regulated information – inside information – Galapagos NV (Euronext & NASDAQ: GLPG), a global biotechnology company dedicated to transforming patient outcomes through [...]
Kuros Biosciences reports 82% year over year increase in sales in the first three months of 2025
15/04/2025
Ad hoc announcement pursuant to Article 53 of the SIX listing rules Kuros Biosciences reports 82% year over year increase in sales in the first three months of 2025 Financial & Operational Highlights Direct MagnetOs [...]

Pages